Bio Protocol is developing an AI-focused biotech infrastructure through its Bio V2 Launchpad. This platform allows patients and researchers globally to utilize decentralized AI agents, known as BioAgents, to streamline scientific knowledge tasks and speed up the process of bringing biotech innovations to market.

The $BIO token serves as the fuel for this BioAgent network, rewarding participants for their input. By staking $BIO, users can operate BioAgents either on local machines or via cloud services to generate yield.

So far, the protocol has introduced three specific BioAgents targeting men’s health, longevity, and microbiome health. Meanwhile, BioDAOs are actively rolling out more agents throughout the ecosystem, working alongside prominent researchers.